Reduced-Intensity versus Myeloablative Conditioning in Cord Blood Transplantation for Acute Myeloid Leukemia (40-60 years) across Highly Mismatched HLA Barriers-On Behalf of Eurocord and the Cellular Therapy & Immunobiology Working Party (CTIWP) of EBMT

The use of myeloablative conditioning (MAC) in umbilical cord blood transplantation (UCBT) has been associated with high nonrelapse mortality (NRM) in patients aged.

Detalles Bibliográficos
Autores: Sheth, Vipul, Volt, Fernanda, Sanz, Jaime|||0000-0001-6934-4619, Clement, Laurence, Cornelissen, Jan, Blaise, Didier|||0000-0002-5684-9447, Malouf Sierra, Jorge|||0000-0001-5185-520X, Michallet, Mauricette, Saccardi, Riccardo|||0000-0002-5763-5467, Rocha, Vanderson, Gluckman, Eliane, Chabannon, Christian|||0000-0002-3755-4889, Ruggeri, Annalisa|||0000-0002-7261-2765
Tipo de recurso: artículo
Fecha de publicación:2020
País:España
Institución:Universitat Autònoma de Barcelona
Repositorio:Dipòsit Digital de Documents de la UAB
Idioma:inglés
OAI Identifier:oai:ddd.uab.cat:284414
Acceso en línea:https://ddd.uab.cat/record/284414
https://dx.doi.org/urn:doi:10.1016/j.bbmt.2020.07.025
Access Level:acceso abierto
Palabra clave:Mismatched
Myeloablative
Reduced intensity
Umbilical cord transplant
Descripción
Sumario:The use of myeloablative conditioning (MAC) in umbilical cord blood transplantation (UCBT) has been associated with high nonrelapse mortality (NRM) in patients aged.